Patent: 8,287,905
✉ Email this page to a colleague
Summary for Patent: 8,287,905
Title: | Pharmaceutical composition of nanoparticles |
Abstract: | The invention discloses a composition of chitosan-shelled nanoparticles and methods of manufacturing. The chitosan-shelled nanoparticles are characterized with a positive surface charge and enhanced epithelial permeability for oral drug delivery. |
Inventor(s): | Sung; Hsing-Wen (Hsinchu, TW), Chuang; Er-Yuan (Hsinchu, TW), Nguyen; Ha Giang Thi (Hsinchu, TW), Su; Fang Yi (Hsinchu, TW), Sonaje; Kiran (Hsinchu, TW), Tu; Hosheng (Newport Beach, CA) |
Assignee: | GP Medical, Inc. (Newport Beach, CA) National Tsing Hua Univresity (Hsinchu, TW) |
Application Number: | 13/438,764 |
Patent Claims: | see list of patent claims |
Details for Patent 8,287,905
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | TANZEUM | albiglutide | For Injection | 125431 | 04/15/2014 | ⤷ Try a Trial | 2025-01-04 |
Sanofi-aventis U.s. Llc | ADLYXIN | lixisenatide | Injection | 208471 | 07/27/2016 | ⤷ Try a Trial | 2025-01-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |